Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kactus Biosystems
Cambridge, Massachusetts, USAlubio.ch ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Kactus Biosystems specializes in providing high-quality recombinant proteins and enzymes, with a focus on complex protein expression and gene editing tools. Their products support drug discovery and development.
- Therapeutic areas
- Other
- Modalities
- Recombinant proteinsenzymesgene editing tools (e.g., CRISPR Cas9)mRNA production enzymes
- Industry
- Non-Drug Biotech
02
Partnerships
Partnerships with companies like Reforgene Medicine for clinical trials
Beyond the preview
Go deeper on Kactus Biosystems.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kactus Biosystems.